High times for drugs: Epigenetic imprint, legacy and brain
Yasmin Hurd, Ph.D.
Professor of Neuroscience, Psychiatry and Pharmacology & Systems Therapeutics
Ward-Coleman Chair of Translational Neuroscience
Director, Center for Addictive Disorders at Mount Sinai Health Systems
Icahn School of Medicine at Mount Sinai
Dr. Hurd is an internationally renowned neuroscientist whose translational research examines the neurobiology of drug abuse and related psychiatric disorders. She is extensively published in the field and leads a team of investigators in molecular biology, behavioral neuropharmacology, genetics and neuroimaging to study the human brain as well as translational animal models. Using multidisciplinary research approaches, her work has provided significant insights into the complex neurobiological mechanisms underlying addictive behavior as well as the molecular neuropathology associated with genetic vulnerability to addiction. Her novel research explores epigenetic mechanisms associated with developmental cannabis exposure that have long-term effects into adulthood and across generations. In addition, Dr. Hurd’s basic science research is complemented by clinical laboratory investigations focused on the development of new treatment interventions.
This page was last updated on Wednesday, August 11, 2021